Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

A manual of diseases of the nervous system
Riluzole inhibits spontaneous Ca2+ signaling in neuroendocrine cells by activation of K+ channels and inhibition of Na+ channels.
Natalizumab-induced autoimmune hepatitis in a patient with multiple sclerosis.
Dual role of Response gene to complement-32 in multiple sclerosis.
Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial
Natalizumab in relapsing-remitting multiple sclerosis.
Renin-angiotensin system gene polymorphisms as risk factors for multiple sclerosis.
▼Dimethyl fumarate for relapsing-remitting multiple sclerosis.
Evaluation of the 9-item Patient Health Questionnaire (PHQ-9) as an assessment instrument for symptoms of depression in patients with multiple sclerosis.
T-cell response against varicella-zoster virus in fingolimod-treated MS patients.
Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis.
Keeping cool: use of air conditioning by australians with multiple sclerosis.
Mast cells: an expanding pathophysiological role from allergy to other disorders.
Significance of Virchow-Robin Spaces in Patients Newly Diagnosed with Multiple Sclerosis: A Case-Control Study in an Arab Population.
CCSVI and MS: a statement from the European Society of neurosonology and cerebral hemodynamics.
Back on the scent: the olfactory system in CNS demyelinating diseases.
Multiple sclerosis and bipolar disorders: The burden of comorbidity and its consequences on quality of life.
B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes.
The nocebo effect: A clinicians guide.
Cyclophosphamide therapy in pediatric multiple sclerosis.
Wnt Signaling in the Pathogenesis of Multiple Sclerosis-Associated Chronic Pain.
Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis.
Fingolimod increases brain-derived neurotrophic factor levels and ameliorates amyloid β-induced memory impairment.
A Study of the Safety and Tolerability of MEDI-551 in Scleroderma
Efficacy and safety of subcutaneous interferon-β-1a in patients with a first demyelinating event and early multiple sclerosis.

Pages